InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Flynn Karen, Président des Biologiques et CCO. Director active across 5 companies, notably Catalent, Inc.. Cumulatively, 18 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €254k. History available since 26 July 2021. The latest transaction was filed on 22 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Flynn Karen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,975 sharesOrdinary SharesSEC:0001193125-26-283788:0
1,493 sharesOrdinary SharesSEC:0001193125-26-283788:1
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242231:0
23,372 shares0Common StockSEC:0001553599-26-000001:0
19,132 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-25-077814:0
7,435 shares0Common StockSEC:0001562180-25-000202:0
20,089 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-24-066037:0
2,947 shares0Common StockSEC:0001562180-24-000232:0
6,993 shares0Common StockSEC:0001596783-23-000153:0
8,083 shares0Common StockSEC:0001562180-23-000102:0
4,149 shares0Common StockSEC:0001596783-22-000169:0
1,066 shares@ US$10.4881.2% of flowCommon StockSEC:0001562180-22-007044:0
245 shares0Common StockSEC:0001596783-22-000142:0
164 shares@ US$16.7918.8% of flowCommon StockSEC:0001562180-22-005558:0
13,227 shares0Common StockSEC:0001562180-22-005091:0
2,472 shares@ US$116.64100.0% of flowCommon StockSEC:0001596783-22-000014:0
1,151 shares0Common StockSEC:0001596783-21-000092:0
10.75 sharesCommon StockSEC:0001225208-16-023358:0
18 of 18 declarations
About Flynn Karen
Flynn Karen is Président des Biologiques et CCO. She has 18 filings in total, and in the 18 sampled filings the activity runs from 2016-01-05 to 2026-06-26, with EUR 0 of buys and EUR 253950 of sells; the main filings concern Catalent, Inc., Quanterix Corp, Stevanato Group S.p.A. and Sotera Health Co.
